世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Canada Specialty Pharmacy Market

Canada Specialty Pharmacy Market


The Canada specialty pharmacy market is expected to reach USD 13.94 billion by 2030 from USD 7.39 billion in 2024, growing at a substantial CAGR of 11.2% in the forecast period of 2025 to 2030. Ma... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
Data Bridge Market Research
データブリッジマーケットリサーチ
2025年4月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
2-3営業日以内 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Canada specialty pharmacy market is expected to reach USD 13.94 billion by 2030 from USD 7.39 billion in 2024, growing at a substantial CAGR of 11.2% in the forecast period of 2025 to 2030.
Market Segmentation:
Canada Specialty Pharmacy Market Segmentation, By Service Type (Clinical Services, Operational Services, and Other Services), Type (Large Pharmacy Benefit Manager (PBM) and Small- Independent Pharmacy Service Providers), Condition (Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Osteoarthritis, Infertility, HIV, Pulmonary Hypertension, Immune Deficiency, Anemia, Hemophilia, Psoriasis, Cystic Fibrosis, Ulcerative Colitis, Crohn's Disease, Juvenile Idiopathic Arthritis, Growth Hormone Deficiencies, Hepatitis C Virus, and Others) - Industry Trends & Forecast to 2030
Overview of the Canada specialty pharmacy market are:

Driver

• Increasing prevalence of chronic and rare diseases

Restrain

• Stringent regulatory framework
Opportunity

• Emerging markets of specialty pharmacies

Market Players:

The key market players for Canada specialty pharmacy market are listed below:

• McKesson Canada (Canada)
• Sobeys Inc. (Canada)
• Rexall Pharmacy Group Ltd. (Canada)
• Bayshore HealthCare (Canada)
• PHARMASAVE (Canada)
• 360Care Denman Pharmacy (Canada)
• Abby Pharmacy (Canada)
• PharmaChoice Canada Inc. (Canada)
• Anchor Compounding Pharmacy (Canada)
• Andreen's Pharmacy (Canada)
• Balanced Health Integrative Pharmacy (Canada)
• Bains Pharmacy (Canada)
• NKS Health (Canada)
• Concord Specialty Pharmacy (Canada)
• BioScript Solutions (Canada)
• McCallum Pharmacy (Canada)
• Lovell Drugs (Canada)
• Create Compounding Limited (Canada)
• Dynasty Pharmacy (Canada)
• Resident Care Pharmacy (Canada)
• Pace Pharmacy (Canada)
• Northmount Pharmacy and Compounding Lab (Canada)
• Victoria Compounding Pharmacy (Canada)
• Aaronson's Compounding Pharmacy (Canada)
• Total Pharmacy (Canada)
• Riverviewguardian.ca (Canada)
• Shoppers Drug Mart Specialty Health Network Inc. (Canada)
• Meds West Ltd. (Canada)
• Rx Connect (Canada)
• London Drugs (Canada)
• Sentrex Health Solutions (Canada)
• Medicine Centre (Canada)
• Aurora Health Care (U.S.)
• Omnicell Inc. (U.S.)
• Onpharm-United (Canada)
• Mountain Health CO-OP (U.S.)
• SRx Health (Canada)
• Compounding Pharmacy New Westminster - Longevity Pharmacy (Canada)
• City Life Pharmacy (Canada)
• Omnicare Pharmacy (U.S.)
• Budget Pharmacy (Canada)
• Torani and Haddad Pharmacy Spec-Pharma (Canada)
• West End Pharmacy (Canada)
• Brunskill Pharmacy (Canada)
• Extend Pharmacy (Canada)
• Sherman Specialty Pharmacy (Canada)
• Quiick Medicine (Canada)
• Pratt's Compounding Pharmacy (Canada)
• Allcures Pharmacy (Canada)
• Alpine Drug Mart I.D.A. (Canada)



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE CANADA SPECIALTY PHARMACY MARKET 14
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 15
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 MULTIVARIATE MODELLING 23
2.7 SERVICES LIFELINE CURVE 24
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.9 DBMR MARKET POSITION GRID 26
2.10 VENDOR SHARE ANALYSIS 27
2.11 SECONDARY SOURCES 28
2.12 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 34
4.1 PESTAL ANALYSIS 35
4.2 PORTERS FIVE FORCES ANALYSIS 36
5 CANADA SPECIALTY PHARMACY MARKET: REGULATIONS 37
6 MARKET OVERVIEW 38
6.1 DRIVERS 40
6.1.1 INCREASING PREVALENCE OF CHRONIC AND RARE DISEASES 40
6.1.2 INCREASING GERIATRIC POPULATION 40
6.1.3 INCREASING NUMBER OF DISTRIBUTION CHANNELS FOR SPECIALITY DRUGS 41
6.2 RESTRAINTS 42
6.2.1 STRINGENT REGULATORY FRAMEWORK 42
6.2.2 LACK OF SKILLED PHARMACISTS 43
6.3 OPPORTUNITIES 44
6.3.1 EMERGING MARKETS OF SPECIALTY PHARMACIES 44
6.3.2 RISING E-PHARMACIES FACILITIES 44
6.4 CHALLENGES 45
6.4.1 LACK OF AWARENESS AMONG CONSUMERS ABOUT SPECIALTY PHARMACIES 45
6.4.2 INSUFFICIENT FUNDING FOR SPECIALITY PHARMACIES 45
7 CANADA SPECIALTY PHARMACY MARKET, BY TYPE 46
7.1 OVERVIEW 47
7.2 LARGE PHARMACY BENEFIT MANAGER (PBM) 50
7.2.1 MANUFACTURER-OWNED SPECIALTY PHARMACIES 50
7.2.2 OWNED SPECIALTY PHARMACIES 50
7.3 SMALL-INDEPENDENT PHARMACY SERVICE PROVIDERS 50
8 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE 51
8.1 OVERVIEW 52
8.2 CLINICAL SERVICES 55
8.2.1 COMPOUNDING 56
8.2.2 AUTO-REFILLS/REFILLS 56
8.2.3 BLISTER PACKAGING 56
8.2.4 MEDICAL CONSULTATIONS 56
8.2.5 CARE MANAGEMENT 56
8.2.6 PATIENT ADHERENCE PROGRAMS 56
8.2.7 HEALTH CARE PROVIDER ACCESS 56
8.2.8 CLINICAL OUTCOME MEASURES 56
8.2.9 RISK EVALUATION AND MITIGATION STRATEGIES (REMS) PROGRAMS 56
8.3 OPERATIONAL SERVICES 57
8.3.1 SUPPLY CHAIN MANAGEMENT 57
8.3.2 CARE COORDINATION 57
8.3.3 INSURANCE NAVIGATION 57
8.3.4 PATIENT ASSISTANCE 57
8.3.5 PLAN OPTIMIZATION 57
9 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION 59
9.1 OVERVIEW 60
9.2 CANCER 63
9.3 RHEUMATOID ARTHRITIS 63
9.4 MULTIPLE SCLEROSIS 64
9.5 OSTEOARTHRITIS 64
9.6 INFERTILITY 64
9.7 HIV 64
9.8 PULMONARY HYPERTENSION 64
9.9 IMMUNE DEFICIENCY 64
9.10 ANEMIA 64
9.11 HEMOPHILIA 64
9.12 PSORIASIS 64
9.13 CYSTIC FIBROSIS 64
9.14 ULCERATIVE COLITIS 65
9.15 CROHN'S DISEASE 65
9.16 JUVENILE IDIOPATHIC ARTHRITIS 65
9.17 GROWTH HORMONE DEFICIENCIES 65
9.18 HEPATITIS C VIRUS 65
9.19 OTHERS 65
10 CANADA SPECIALTY PHARMACY MARKET, COMPANY LANDSCAPE 66
10.1 COMPANY SHARE ANALYSIS: GLOBAL 66
11 SWOT ANALYSIS 67
12 COMPANY PROFILES 68
12.1 MCKESSON CANADA 68
12.1.1 COMPANY SNAPSHOT 68
12.1.2 SERVICE PORTFOLIO 68
12.1.3 RECENT DEVELOPMENTS 68
12.2 SOBEYS INC. 69
12.2.1 COMPANY SNAPSHOT 69
12.2.2 SERVICE PORTFOLIO 69
12.2.3 RECENT DEVELOPMENTS 69
12.3 REXALL PHARMACY GROUP LTD. 70
12.3.1 COMPANY SNAPSHOT 70
12.3.2 SERVICE PORTFOLIO 70
12.3.3 RECENT DEVELOPMENTS 70
12.4 BAYSHORE HEALTHCARE 72
12.4.1 COMPANY SNAPSHOT 72
12.4.2 SERVICE PORTFOLIO 72
12.4.3 RECENT DEVELOPMENTS 73
12.5 PHARMASAVE 74
12.5.1 COMPANY SNAPSHOT 74
12.5.2 SERVICE PORTFOLIO 74
12.5.3 RECENT DEVELOPMENTS 74
12.6 AARONSON'S COMPOUNDING PHARMACY 76
12.6.1 COMPANY SNAPSHOT 76
12.6.2 SERVICE PORTFOLIO 76
12.6.3 RECENT DEVELOPMENTS 76
12.7 ANCHOR COMPOUNDING PHARMACY 77
12.7.1 COMPANY SNAPSHOT 77
12.7.2 SERVICE PORTFOLIO 77
12.7.3 RECENT DEVELOPMENTS 78
12.8 ABBY PHARMACY 79
12.8.1 COMPANY SNAPSHOT 79
12.8.2 SERVICE PORTFOLIO 79
12.8.3 RECENT DEVELOPMENTS 80
12.9 AURORA HEALTHCARE 81
12.9.1 COMPANY SNAPSHOT 81
12.9.2 SERVICE PORTFOLIO 81
12.9.3 RECENT DEVELOPMENTS 82
12.10 ALLCURES PHARMACY 83
12.10.1 COMPANY SNAPSHOT 83
12.10.2 SERVICE PORTFOLIO 83
12.10.3 RECENT DEVELOPMENTS 84
12.11 ALPINE DRUG MART I.D.A. 85
12.11.1 COMPANY SNAPSHOT 85
12.11.2 PRODUCT PORTFOLIO 85
12.11.3 RECENT DEVELOPMENTS 86
12.12 ANDREEN'S PHARMACY 87
12.12.1 COMPANY SNAPSHOT 87
12.12.2 SERVICE PORTFOLIO 87
12.12.3 RECENT DEVELOPMENTS 88
12.13 BRUNSKILLPHARMACY 89
12.13.1 COMPANY SNAPSHOT 89
12.13.2 SERVICE PORTFOLIO 89
12.13.3 RECENT DEVELOPMENTS 90
12.14 BAINS PHARMACY 91
12.14.1 COMPANY SNAPSHOT 91
12.14.2 PRODUCT PORTFOLIO 91
12.14.3 RECENT DEVELOPMENTS 92
12.15 BIOSCRIPT SOLUTIONS 93
12.15.1 COMPANY SNAPSHOT 93
12.15.2 SERVICE PORTFOLIO 93
12.15.3 RECENT DEVELOPMENTS 94
12.16 BUDGET PHARMACY 95
12.16.1 COMPANY SNAPSHOT 95
12.16.2 SERVICE PORTFOLIO 95
12.16.3 RECENT DEVELOPMENTS 95
12.17 BALANCED HEALTH INTEGRATIVE PHARMACY 96
12.17.1 COMPANY SNAPSHOT 96
12.17.2 SERVICE PORTFOLIO 96
12.17.3 RECENT DEVELOPMENTS 97
12.18 COMPOUNDING PHARMACY NEW WESTMINSTER - LONGEVITY PHARMACY 98
12.18.1 COMPANY SNAPSHOT 98
12.18.2 SERVICE PORTFOLIO 98
12.18.3 RECENT DEVELOPMENTS 98
12.19 CITY LIFE PHARMACY 99
12.19.1 COMPANY SNAPSHOT 99
12.19.2 SERVICE PORTFOLIO 99
12.19.3 RECENT DEVELOPMENTS 100
12.20 CREATE COMPOUNDING LIMITED 101
12.20.1 COMPANY SNAPSHOT 101
12.20.2 SERVICE PORTFOLIO 101
12.20.3 RECENT DEVELOPMENTS 101
12.21 CONCORD SPECIALTY PHARMACY 102
12.21.1 COMPANY SNAPSHOT 102
12.21.2 SERVICE PORTFOLIO 102
12.21.3 RECENT DEVELOPMENTS 102
12.22 360CARE DENMAN PHARMACY 103
12.22.1 COMPANY SNAPSHOT 103
12.22.2 SERVICE PORTFOLIO 103
12.22.3 RECENT DEVELOPMENTS 104
12.23 DYNASTY PHARMACY 105
12.23.1 COMPANY SNAPSHOT 105
12.23.2 SERVICE PORTFOLIO 105
12.23.3 RECENT DEVELOPMENTS 105
12.24 EXTEND PHARMACY 106
12.24.1 COMPANY SNAPSHOT 106
12.24.2 SERVICE PORTFOLIO 106
12.24.3 RECENT DEVELOPMENTS 106
12.25 LONDON DRUGS 107
12.25.1 COMPANY SNAPSHOT 107
12.25.2 SERVICE PORTFOLIO 107
12.25.3 RECENT DEVELOPMENTS 107
12.26 LOVELL DRUGS 108
12.26.1 COMPANY SNAPSHOT 108
12.26.2 SERVICE PORTFOLIO 108
12.26.3 RECENT DEVELOPMENTS 109
12.27 MEDICINE CENTRE 110
12.27.1 COMPANY SNAPSHOT 110
12.27.2 SERVICE PORTFOLIO 110
12.27.3 RECENT DEVELOPMENTS 110
12.28 MOUNTAIN HEALTH CO-OP 111
12.28.1 COMPANY SNAPSHOT 111
12.28.2 SERVICE PORTFOLIO 111
12.28.3 RECENT DEVELOPMENTS 111
12.29 MEDS WEST LTD. 112
12.29.1 COMPANY SNAPSHOT 112
12.29.2 SERVICE PORTFOLIO 112
12.29.3 RECENT DEVELOPMENTS 112
12.30 MCCALLUM PHARMACY 113
12.30.1 COMPANY SNAPSHOT 113
12.30.2 SERVICE PORTFOLIO 113
12.30.3 RECENT DEVELOPMENTS 115
12.31 NORTHMOUNT PHARMACY AND COMPOUNDING LAB 116
12.31.1 COMPANY SNAPSHOT 116
12.31.2 SERVICE PORTFOLIO 116
12.31.3 RECENT DEVELOPMENTS 116
12.32 NKS HEALTH 117
12.32.1 COMPANY SNAPSHOT 117
12.32.2 SERVICE PORTFOLIO 117
12.32.3 RECENT DEVELOPMENTS 118
12.33 ONPHARM-UNITED 119
12.33.1 COMPANY SNAPSHOT 119
12.33.2 SERVICE PORTFOLIO 119
12.33.3 RECENT DEVELOPMENTS 120
12.34 OMNICARE PHARMACY 121
12.34.1 COMPANY SNAPSHOT 121
12.34.2 SERVICE PORTFOLIO 121
12.34.3 RECENT DEVELOPMENTS 121
12.35 OMNICELL INC. 122
12.35.1 COMPANY SNAPSHOT 122
12.35.2 REVENUE ANALYSIS 122
12.35.3 SERVICE PORTFOLIO 123
12.35.4 RECENT DEVELOPMENT 124
12.36 PHARMACHOICE CANADA INC. 126
12.36.1 COMPANY SNAPSHOT 126
12.36.2 SERVICE PORTFOLIO 126
12.36.3 RECENT DEVELOPMENTS 128
12.37 PRATT'S COMPOUNDING PHARMACY 129
12.37.1 COMPANY SNAPSHOT 129
12.37.2 SERVICE PORTFOLIO 129
12.37.3 RECENT DEVELOPMENTS 131
12.38 PACE PHARMACY 132
12.38.1 COMPANY SNAPSHOT 132
12.38.2 SERVICE PORTFOLIO 132
12.38.3 RECENT DEVELOPMENTS 132
12.39 QUIICK MEDICINE 133
12.39.1 COMPANY SNAPSHOT 133
12.39.2 SERVICE PORTFOLIO 133
12.39.3 RECENT DEVELOPMENTS 134
12.40 RX CONNECT 135
12.40.1 COMPANY SNAPSHOT 135
12.40.2 SERVICE PORTFOLIO 135
12.40.3 RECENT DEVELOPMENTS 135
12.41 RIVERVIEWGUARDIAN.CA 136
12.41.1 COMPANY SNAPSHOT 136
12.41.2 SERVICE PORTFOLIO 136
12.41.3 RECENT DEVELOPMENTS 137
12.42 RESIDENT CARE PHARMACY 138
12.42.1 COMPANY SNAPSHOT 138
12.42.2 SERVICE PORTFOLIO 138
12.42.3 RECENT DEVELOPMENTS 139
12.43 SHERMANSPECIALTY PHARMACY 140
12.43.1 COMPANY SNAPSHOT 140
12.43.2 SERVICE PORTFOLIO 140
12.43.3 3.43.3. RECENT DEVELOPMENTS 142
12.44 SHOPPERS DRUG MART SPECIALTY HEALTH NETWORK INC. 143
12.44.1 COMPANY SNAPSHOT 143
12.44.2 SERVICE PORTFOLIO 143
12.44.3 RECENT DEVELOPMENTS 143
12.45 SRX HEALTH 144
12.45.1 COMPANY SNAPSHOT 144
12.45.2 SERVICE PORTFOLIO 144
12.45.3 RECENT DEVELOPMENTS 145
12.46 SENTREX HEALTH SOLUTIONS 146
12.46.1 COMPANY SNAPSHOT 146
12.46.2 SERVICE PORTFOLIO 146
12.46.3 RECENT DEVELOPMENTS 146
12.47 TORANI AND HADDAD PHARMACY SPEC- PHARMA 147
12.47.1 COMPANY SNAPSHOT 147
12.47.2 SERVICE PORTFOLIO 147
12.47.3 RECENT DEVELOPMENTS 148
12.48 TOTAL PHARMACY 149
12.48.1 COMPANY SNAPSHOT 149
12.48.2 SERVICE PORTFOLIO 149
12.48.3 RECENT DEVELOPMENTS 150
12.49 VICTORIA COMPOUNDING PHARMACY 151
12.49.1 COMPANY SNAPSHOT 151
12.49.2 SERVICE PORTFOLIO 151
12.49.3 RECENT DEVELOPMENTS 152
12.50 WEST END PHARMACY 153
12.50.1 COMPANY SNAPSHOT 153
12.50.2 SERVICE PORTFOLIO 153
12.50.3 RECENT DEVELOPMENTS 154
13 QUESTIONNAIRE 155
14 RELATED REPORTS 158

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(pharmacy)の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/10/21 10:26

151.56 円

176.95 円

205.98 円

ページTOPに戻る